Addus HomeCare (ADUS) 10-Q 6 Aug 24 2024 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Jul. 30, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Entity Registrant Name	ADDUS HOMECARE CORPORATION
Entity Central Index Key	0001468328
Trading Symbol	ADUS
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Address, State or Province	TX
Entity File Number	001-34504
Entity Tax Identification Number	20-5340172
Entity Address, Address Line One	6303 Cowboys Way
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Frisco
Entity Address, Postal Zip Code	75034
City Area Code	469
Local Phone Number	535-8200
Entity Common Stock, Shares Outstanding		18,100,285
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Title of 12(b) Security	Common Stock, $0.001 par value
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash	$ 173,305	$ 64,791
Accounts receivable, net of allowances	109,195	115,499
Prepaid expenses and other current assets	12,488	19,714
Total current assets	294,988	200,004
Property and equipment, net of accumulated depreciation and amortization	23,381	24,011
Other assets
Goodwill	663,851	662,995
Intangibles, net of accumulated amortization	88,398	91,983
Operating lease assets, net	44,145	45,433
Other long-term assets	1,791
Total other assets	798,185	800,411
Total assets	1,116,554	1,024,426
Current liabilities
Accounts payable	20,188	26,183
Accrued payroll	55,102	56,551
Accrued expenses	35,633	33,236
Operating lease liabilities, current portion	11,224	11,339
Government stimulus advances	13,000	5,765
Accrued workers' compensation insurance	12,385	12,043
Total current liabilities	147,532	145,117
Long-term liabilities
Long-term debt, net of debt issuance costs		124,132
Long-term operating lease liabilities	38,359	39,711
Other long-term liabilities	9,008	8,772
Total long-term liabilities	47,367	172,615
Total liabilities	194,899	317,732
Stockholders' equity
Common stock $.001 par value; 40,000 authorized and 18,100 and 16,227 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	18	16
Additional paid-in capital	584,896	403,846
Retained earnings	336,741	302,832
Total stockholders' equity	921,655	706,694
Total liabilities and stockholders' equity	$ 1,116,554	$ 1,024,426

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	18,100,000	16,227,000
Common stock, shares outstanding	18,100,000	16,227,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Net service revenues	$ 286,922	$ 259,980	$ 567,668	$ 511,579
Cost of service revenues	193,764	177,662	386,333	350,846
Gross profit	93,158	82,318	181,335	160,733
General and administrative expenses	63,576	57,397	124,639	113,757
Depreciation and amortization	3,401	3,382	6,870	6,829
Total operating expenses	66,977	60,779	131,509	120,586
Operating income	26,181	21,539	49,826	40,147
Interest income	(474)	(291)	(897)	(397)
Interest expense	2,114	2,331	4,872	4,792
Total interest expense, net	1,640	2,040	3,975	4,395
Income before income taxes	24,541	19,499	45,851	35,752
Income tax expense	6,462	4,647	11,942	8,225
Net income	$ 18,079	$ 14,852	$ 33,909	$ 27,527
Net income per common share
Basic income per share	$ 1.12	$ 0.93	$ 2.10	$ 1.72
Diluted income per share	$ 1.1	$ 0.91	$ 2.06	$ 1.69
Weighted average number of common shares and potential common shares outstanding:
Basic	16,177	16,002	16,120	15,975
Diluted	16,498	16,283	16,449	16,304

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2022	$ 633,540	$ 16	$ 393,208	$ 240,316
Balance, shares at Dec. 31, 2022		16,128
Issuance of shares of common stock under restricted stock award agreements, shares		86
Stock-based compensation	5,259		5,259
Shares issued for exercise of stock options	25		25
Net income	27,527			27,527
Balance at Jun. 30, 2023	666,351	$ 16	398,492	267,843
Balance, shares at Jun. 30, 2023		16,214
Balance at Mar. 31, 2023	648,886	$ 16	395,879	252,991
Balance, shares at Mar. 31, 2023		16,204
Issuance of shares of common stock under restricted stock award agreements, shares		10
Stock-based compensation	2,613		2,613
Net income	14,852			14,852
Balance at Jun. 30, 2023	666,351	$ 16	398,492	267,843
Balance, shares at Jun. 30, 2023		16,214
Balance at Dec. 31, 2023	706,694	$ 16	403,846	302,832
Balance, shares at Dec. 31, 2023		16,227
Issuance of shares of common stock under restricted stock award agreements, shares		151
Forfeiture of shares of common stock under restricted stock award agreements, shares		(3)
Stock-based compensation	5,474		5,474
Shares issued in public offering, net of offering costs,Shares	175,578	$ 2	175,576
Shares issued in public offering, net of offering costs, Shares		1,725
Net income	33,909			33,909
Balance at Jun. 30, 2024	921,655	$ 18	584,896	336,741
Balance, shares at Jun. 30, 2024		18,100
Balance at Mar. 31, 2024	725,143	$ 16	406,465	318,662
Balance, shares at Mar. 31, 2024		16,370
Issuance of shares of common stock under restricted stock award agreements, shares		8
Forfeiture of shares of common stock under restricted stock award agreements, shares		(3)
Stock-based compensation	2,855		2,855
Shares issued in public offering, net of offering costs,Shares	175,578	$ 2	175,576
Shares issued in public offering, net of offering costs, Shares		1,725
Net income	18,079			18,079
Balance at Jun. 30, 2024	$ 921,655	$ 18	$ 584,896	$ 336,741
Balance, shares at Jun. 30, 2024		18,100

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income	$ 33,909	$ 27,527
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization	6,870	6,829
Deferred income taxes	264	165
Stock-based compensation	5,474	5,259
Amortization of debt issuance costs under the credit facility	430	430
Provision for credit losses	486	313
Gain on disposal of assets	(5)
Loss on termination of operating leases	10
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	5,362	21,395
Prepaid expenses and other current assets	7,127	(4,018)
Government stimulus advances	7,235	(3,382)
Accounts payable	(6,333)	(597)
Accrued payroll	(1,449)	2,788
Accrued expenses and other long-term liabilities	(1,889)	3,704
Net cash provided by operating activities	57,491	60,413
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(400)	(940)
Purchases of property and equipment	(2,421)	(1,771)
Proceeds received from disposal of assets	19
Proceeds received from divestiture of business	4,600
Net cash provided by (used in) investing activities	1,798	(2,711)
Cash flows from financing activities:
Payments on revolver loan — credit facility	(126,353)	(53,500)
Proceeds from Public offering	175,578
Cash received from exercise of stock options		25
Net cash provided by (used in) financing activities	49,225	(53,475)
Net change in cash	108,514	4,227
Cash, at beginning of period	64,791	79,961
Cash, at end of period	173,305	84,188
Supplemental disclosures of cash flow information:
Cash paid for interest	4,491	4,416
Cash paid for income taxes	$ 13,986	$ 6,767

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 18,079	$ 14,852	$ 33,909	$ 27,527

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	During the quarter ending June 30, 2024, each of the following directors and Section 16 officers adopted a Rule 10b5-1 Trading Arrangement (as defined in Item 408(a) of Regulation S-K) to sell common shares: Name Title Adoption Date Expiration Date (1) Shares Vesting and Subject to Sell-To-Cover (2) Other Shares Being Sold (Subject to Certain Conditions) Roberton Stevenson EVP and Chief Human Resources Officer June 12, 2024 June 14, 2025 3,330 n/a Michael Wattenbarger EVP and Chief Information Officer June 12, 2024 February 24, 2025 3,539 n/a R. Dirk Allison Chief Executive Officer and Chairman of the Board June 12, 2024 February 24, 2025 26,609 n/a Darby Anderson EVP and Chief Government Affairs & Community Relations Officer June 12, 2024 February 24, 2025 4,823 n/a W. Bradley Bickham President and Chief Operating Officer June 13, 2024 February 24, 2025 14,308 n/a Cliff Blessing EVP and Chief Development Officer June 12, 2024 April 20, 2025 2,752 n/a Brian Poff EVP, Chief Financial Officer, Secretary and Treasurer June 12, 2024 February 24, 2025 13,207 n/a Monica Raines EVP and Chief Compliance and Quality Officer June 13, 2024 March 1, 2025 3,168 n/a Sean Gaffney EVP and Chief Legal Officer June 14, 2024 February 24, 2025 4,823 n/a Brian Poff EVP, Chief Financial Officer, Secretary and Treasurer June 13, 2024 December 13, 2024 n/a 6,839 David Tucker EVP and Chief Strategy Officer June 14, 2024 February 24, 2025 4,142 n/a ( 1) Each plan will expire on the date represented in the table or upon the earlier completion of all transactions contemplated by the arrangement. (2) This column indicates the total number of shares vesting in connection with equity awards, not the number of shares to be sold. The actual number of shares to be sold will be a smaller number based on whatever is required to satisfy payment of applicable withholding taxes under sell-to-cover arrangements.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Roberton Stevenson
Trading Arrangements, by Individual
Name	Roberton Stevenson
Title	EVP and Chief Human Resources Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 12, 2024
Expiration Date	June 14, 2025
Aggregate Available	3,330
Michael Wattenbarger
Trading Arrangements, by Individual
Name	Michael Wattenbarger
Title	EVP and Chief Information Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 12, 2024
Expiration Date	February 24, 2025
Aggregate Available	3,539
R. Dirk Allison
Trading Arrangements, by Individual
Name	R. Dirk Allison
Title	Chief Executive Officer and Chairman of the Board
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 12, 2024
Expiration Date	February 24, 2025
Aggregate Available	26,609
Darby Anderson
Trading Arrangements, by Individual
Name	Darby Anderson
Title	EVP and Chief Government Affairs & Community Relations Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 12, 2024
Expiration Date	February 24, 2025
Aggregate Available	4,823
W. Bradley Bickham
Trading Arrangements, by Individual
Name	W. Bradley Bickham
Title	President and Chief Operating Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 13, 2024
Expiration Date	February 24, 2025
Aggregate Available	14,308
Cliff Blessing
Trading Arrangements, by Individual
Name	Cliff Blessing
Title	EVP and Chief Development Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 12, 2024
Expiration Date	April 20, 2025
Aggregate Available	2,752
Brian Poff
Trading Arrangements, by Individual
Name	Brian Poff
Title	EVP, Chief Financial Officer, Secretary and Treasurer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 12, 2024
Expiration Date	February 24, 2025
Aggregate Available	13,207
Monica Raines
Trading Arrangements, by Individual
Name	Monica Raines
Title	EVP and Chief Compliance and Quality Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 13, 2024
Expiration Date	March 1, 2025
Aggregate Available	3,168
Sean Gaffney
Trading Arrangements, by Individual
Name	Sean Gaffney
Title	EVP and Chief Legal Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 14, 2024
Expiration Date	February 24, 2025
Aggregate Available	4,823
Brian Poff
Trading Arrangements, by Individual
Name	Brian Poff
Title	EVP, Chief Financial Officer, Secretary and Treasurer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 13, 2024
Expiration Date	December 13, 2024
Aggregate Available	6,839
David Tucker
Trading Arrangements, by Individual
Name	David Tucker
Title	EVP and Chief Strategy Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 14, 2024
Expiration Date	February 24, 2025
Aggregate Available	4,142

Nature of Operations, Consolida

Nature of Operations, Consolidation, and Presentation of Financial Statements	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations, Consolidation, and Presentation of Financial Statements	1. Nature of Operations, Consolidation and Presentation of Financial Statements Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us” or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care services segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy. The Company’s payors include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals. Basis of Presentation The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2023 has been derived from the Company’s audited financial statements for the year ended December 31, 2023 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2023 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period. Principles of Consolidation These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Estimates The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles in business combinations and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates. Computation of Weighted Average Shares The following table sets forth the computation of basic and diluted common shares: For the Three Months Ended June 30, For the Six Months Ended June 30, (Amounts in thousands) (Amounts in thousands) 2024 2023 2024 2023 Weighted average number of shares outstanding for basic per share 16,177 16,002 16,120 15,975 Effect of dilutive potential shares: Stock options 251 237 239 245 Restricted stock awards 70 44 90 84 Adjusted weighted average shares outstanding for diluted per share 16,498 16,283 16,449 16,304 Anti-dilutive shares: Stock options 19 61 42 61 Restricted stock awards 8 77 8 1 Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. The ASU was adopted prospectively on January 1, 2023 . The additional disclosures required did no t have a material impact on our consolidated financial statements. Recently Issued Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures , which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Annual disclosures are required for fiscal years beginning after December 15, 2023 and interim disclosures are required for periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. These requirements will result in expanded disclosures. In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures , which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied prospectively or retrospectively, and allows for early adoption . These requirements are no t expected to have an impact on the Company's financial statements and will expand income tax disclosures.

Public Offering

Public Offering	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
Public Offering	3. Public Offering On June 28, 2024, the Company completed a public offering of an aggregate 1,725,000 shares of common stock, par value $ 0.001 per share, including 225,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares, at a public offering price of $ 108.00 per share (the “Public Offering”). The Company received net proceeds of approximately $ 175.6 million, after deducting underwriting discounts and estimated offering expenses of approximately $ 10.7 million. The Company used approximately $ 81.4 million from the net proceeds of the Public Offering for the repayment of indebtedness outstanding under its credit facility and may use any remaining net proceeds of the Public Offering for general corporate purposes, including the Company’s previously announced planned acquisition of the personal care assets of Gentiva and any future acquisitions or investments. The Public Offering resulted in an increase to additional paid in capital of approximately $ 175.6 million on the Company’s Unaudited Condensed Consolidated Balance Sheets at June 30, 2024.

Acquisition and Divestiture

Acquisition and Divestiture	6 Months Ended
	Jun. 30, 2024
Business Combinations [Abstract]
Acquisition and Divestiture	4. Acquisition and Divestiture Acquisition On June 8, 2024, the Company entered into a definitive stock and asset purchase agreement (the “Gentiva Purchase Agreement”) to acquire the personal care operations of Curo Health Services, LLC, a Delaware limited liability company which does business as Gentiva (“Gentiva”), consisting of equity interests and certain assets and liabilities, for a purchase price of approximately $ 350.0 million, payable in full in cash at the closing, subject to typical adjustments for working capital and other customary items (collectively, the “Gentiva Acquisition”). The acquired business operates in Arizona, Arkansas, California, Missouri, North Carolina, Tennessee and Texas, and serves approximately 16,000 patients. The Company expects to close this acquisition following completion of regulatory approvals and subject to customary closing conditions and fund it through the Company’s existing revolving credit facility and a portion of the net proceeds from the Public Offering. Divestiture On May 21, 2024, the Company entered into a definitive asset purchase agreement to sell all of the Company’s New York operations for a purchase price of up to $ 23.0 million in cash, subject to certain adjustments, including adjustments for future operating requirements (the “New York Asset Sale”). The Company entered into a consulting agreement with the purchaser on May 21, 2024, as the transfer of clients and caregivers and payment for assets pursuant to the New York Asset Sale is occurring over time as regulatory approvals are received, coordination of the transfer of clients and caregivers occurs, and the change of control takes place. In connection with this transaction, the Company will cease operations in New York. During the three months ended June 30, 2024, the Company recorded $ 0.7 million in consulting fees and received a $ 4.6 million initial payment on the acquisition. The New York Asset Sale did not qualify as a discontinued operation because it did not represent a strategic shift that has or will have a major effect on the Company’s operation or financial results. As of May 21, 2024, the Company’s New York personal care operations met the criteria to be classified as held for sale. The carrying value does not exceed the fair market value and will result in a gain on divestiture once the transaction closes. The carrying amounts of the assets and liabilities associated with our New York personal care operations included in our Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 were as follows (amounts in thousands): June 30, 2024 Assets Current assets Accounts receivable, net of allowances $ 7,712 Prepaid expenses and other current assets 3 Total current assets 7,715 Property and equipment, net of accumulated depreciation and amortization 34 Other assets Goodwill 3,801 Intangibles, net of accumulated amortization 4,841 Operating lease assets, net 3,727 Total other assets 12,369 Total assets $ 20,118 Liabilities Current liabilities Accounts payable $ 6,340 Accrued payroll 3,531 Accrued expenses 753 Operating lease liabilities, current portion 790 Total current liabilities 11,414 Long-term liabilities Other long-term liabilities 2,829 Total liabilities $ 14,243

Leases

Leases	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Leases	5. Leases Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows: June 30, 2024 December 31, 2023 (Amounts in Thousands) Operating lease assets, net $ 44,145 $ 45,433 Short-term operating lease liabilities (in accrued expenses ) 11,224 11,339 Long-term operating lease liabilities 38,359 39,711 Total operating lease liabilities $ 49,583 $ 51,050 Lease Costs Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows: For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Operating lease costs $ 3,373 $ 3,292 $ 6,669 $ 6,334 Short-term lease costs 179 284 380 700 Total lease costs 3,552 3,576 7,049 7,034 Less: sublease income ( 491 ) ( 700 ) ( 1,089 ) ( 1,399 ) Total lease costs, net $ 3,061 $ 2,876 $ 5,960 $ 5,635 Lease Term and Discount Rate Weighted average remaining lease terms and discount rates were as follows: June 30, 2024 December 31, 2023 Operating leases: Weighted average remaining lease term (years) 5.98 6.26 Weighted average discount rate 5.80 % 5.47 % Maturity of Lease Liabilities Remaining operating lease payments as of June 30, 2024 were as follows: Operating Leases (Amounts in Thousands) Due in the 12-month period ended June 30, 2025 $ 7,368 2026 11,955 2027 9,534 2028 6,974 2029 5,707 Thereafter 17,799 Total future minimum rental commitments 59,337 Less: Imputed interest ( 9,754 ) Total lease liabilities $ 49,583 Supplemental Cash Flows Information For the Six Months Ended June 30, (Amounts in Thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 7,224 $ 7,010 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 4,509 $ 14,415

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	6. Goodwill and Intangible Assets A summary of the goodwill and related adjustments is provided below: Hospice Personal Care Home Health Total (Amounts in Thousands) Goodwill as of December 31, 2023 $ 432,799 $ 153,276 $ 76,920 $ 662,995 Additions for acquisitions — 400 — 400 Adjustments to previously recorded goodwill 38 — 418 456 Goodwill as of June 30, 2024 $ 432,837 $ 153,676 $ 77,338 $ 663,851 On March 9, 2024, the Company completed its acquisition of the operations of Upstate Home Care Solutions (“Upstate”) for $ 0.4 million. With the purchase of Upstate, the Company expanded its personal care services segment in South Carolina. In connection with the Upstate acquisition, the Company recognized goodwill in its personal care segment of $ 0.4 million during the six months ended June 30, 2024. The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty years . Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years . The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following: June 30, 2024 December 31, 2023 (Amounts in Thousands) (Amounts in Thousands) Estimated Useful Life Gross carrying value Accumulated amortization Net carrying value Gross carrying value Accumulated amortization Net carrying value Customer and referral relationships 5 - 10 years $ 44,672 $ ( 40,248 ) $ 4,424 $ 44,672 $ ( 39,566 ) $ 5,106 Trade names and trademarks 1 - 20 years 59,566 ( 25,360 ) 34,206 59,566 ( 23,857 ) 35,709 Non-competition agreement 3 - 5 years 6,785 ( 6,009 ) 776 6,785 ( 5,601 ) 1,184 State Licenses 6 - 10 years 12,671 ( 10,007 ) 2,664 12,671 ( 9,015 ) 3,656 State Licenses Indefinite 46,328 — 46,328 46,328 — 46,328 Total intangible assets $ 170,022 $ ( 81,624 ) $ 88,398 $ 170,022 $ ( 78,039 ) $ 91,983 Amortization expense related to the intangible assets was $ 1.8 million and $ 3.6 million for the three and six months ended June 30, 2024 , respectively, and $ 1.7 million and $ 3.5 million for the three and six months ended June 30, 2023, respectively. The weighted average remaining useful lives of identifiable intangible assets as of June 30, 2024 was 10.1 years.

Details of Certain Balance Shee

Details of Certain Balance Sheet Accounts	6 Months Ended
	Jun. 30, 2024
Details Of Certain Balance Sheet Accounts [Abstract]
Details of Certain Balance Sheet Accounts	7. Details of Certain Balance Sheet Accounts Prepaid expenses and other current assets consisted of the following: June 30, 2024 December 31, 2023 (Amounts in Thousands) Prepaid payroll $ — $ 8,735 Prepaid workers' compensation and liability insurance 4,411 3,696 Prepaid licensing fees 4,874 4,481 Workers' compensation insurance receivable 623 577 Other 2,580 2,225 Total prepaid expenses and other current assets $ 12,488 $ 19,714 Accrued expenses consisted of the following: June 30, 2024 December 31, 2023 (Amounts in Thousands) Accrued health benefits 7,061 7,400 Payor advances (1) — 1,218 Accrued professional fees 8,389 7,304 Accrued payroll and other taxes 6,256 8,572 Other (2) 13,927 8,742 Total accrued expenses $ 35,633 $ 33,236 (1) Represents the deferred portion of payments received from payors for COVID-19 reimbursements which was recognized as we incurred specific COVID-19 related expenses (including expenses related to securing and maintaining adequate personnel). (2) Includes a $ 4.6 million initial payment received for the New York Asset Sale as of June 30, 2024 .

Government Actions to Mitigate

Government Actions to Mitigate COVID-19's Impact	6 Months Ended
	Jun. 30, 2024
Risks and Uncertainties [Abstract]
Government Actions to Mitigate COVID-19's Impact	8. Government Actions to Mitigate COVID-19’s Impact While the acute phase of the COVID-19 pandemic has faded, we will continue to closely monitor the impact of COVID-19 on all aspects of our business, including the impacts to our employees, patients and suppliers. In recognition of the significant threat to the liquidity of financial markets posed by the COVID-19 pandemic, the Federal Reserve and Congress took dramatic actions to provide liquidity to businesses and the banking system in the United States, including relief for healthcare providers in the Coronavirus Aid, Relief, and Economic Stability Act (“CARES Act”), which was expanded by the Paycheck Protection Program and Health Care Enhancement Act, and the Consolidated Appropriations Act, 2021 (“CAA”), as well as the American Rescue Plan Act of 2021 (“ARPA”). ARPA Spending Plans The ARPA provides for $ 350 billion in relief funding for eligible state, local, territorial, and Tribal governments to mitigate the fiscal effects of the COVID-19 public health emergency. Additionally, the law provided for a 10 percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States are permitted to use the state funds equivalent to the additional federal funds through March 31, 2025. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021. HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses. During the three and six months ended June 30, 2024 , the Company received additional state funding provided by the ARPA in an aggregate amount of $ 2.0 million and $ 12.2 million, respectively. The Company did no t record revenue and related costs of service revenue during the three and six months ended June 30, 2024 because revenue recognition criteria were not met. Instead, the Company deferred recognition of the entire $ 12.2 million, which was received from states with specific spending plans and reporting requirements. Of the total state funding received by the Company pursuant to the ARPA through June 30, 2024 , the Company utilized $ 2.5 million and $ 4.9 million during the three and six months ended June 30, 2024, respectively, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of June 30, 2024 , the deferred portion of ARPA funding of $ 13.0 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets. Medicare Sequester The CARES Act and related legislation also include other provisions offering financial relief, including, for example, temporarily suspending the Medicare sequester, which would have otherwise reduced payments to Medicare providers by 2 % as required by the Budget Control Act of 2011. The sequestration adjustment resumed with a 1 % reduction beginning April 1, 2022, and a 2 % reduction beginning July 1, 2022. These sequestration cuts have been extended through April 2032. The ARPA increased the federal budget deficit in a manner that triggers an additional statutorily mandated sequestration under the PAYGO Act. As a result, an additional Medicare payment reduction of up to 4 % was required to take effect in January 2022. However, Congress has delayed implementation of this payment reduction until 2025.

Long-Term Debt

Long-Term Debt	6 Months Ended
	Jun. 30, 2024
Long-Term Debt, Unclassified [Abstract]
Long-Term Debt	9. Long-Term Debt Long-term debt consisted of the following: June 30, 2024 December 31, 2023 (Amounts in Thousands) Revolving loan under the credit facility $ — $ 126,353 Less unamortized issuance costs (1) — ( 2,221 ) Long-term debt $ — $ 124,132 (1) As of June 30, 2024, unamortized issuance costs $ 1.8 million are recorded in Other long-term assets on the Company ’ s Unaudited Condensed Consolidated Balance Sheets. Amended and Restated Senior Secured Credit Facility On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021, and as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023 (as described below, the “Third Amendment”) (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $ 600.0 million revolving credit facility and a $ 125.0 million incremental loan facility, which incremental loan facility may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2026 . On April 26, 2023, the Company entered into the Third Amendment to replace LIBOR with the Secured Overnight Financing Rate (“SOFR”) as the benchmark reference rate for loans under its credit facility. The Third Amendment did not amend any other terms of the Credit Agreement. The transition to SOFR did not and is not expected to have a material impact on the Company’s results of operations or liquidity. Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75 % to 1.50 % based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50 % and (c) the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for an interest period of one month for such applicable day plus 0.10 % (not to be less than 0.00 %), plus a margin of 1.00 % or (y) the sum of (i) an applicable margin ranging from 1.75 % to 2.50 % based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for the applicable interest period plus 0.10 % (not to be less than zero ). Swing loans may not be SOFR loans. Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75 :1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25 :1.00 for the then current fiscal quarter and the three succeeding fiscal quarters. The Company pays a fee ranging from 0.20 % to 0.35 % based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility. The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement), a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures. The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $ 7.5 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business. During the six months ended June 30, 2024, the Company did no t draw on its credit facility and repaid all amounts owed under the revolving credit facility. During the six months ended June 30, 2023, the Company did no t draw on its credit facility and repaid $ 53.5 million under the revolving credit facility. At June 30, 2024 , the Company had no revolving loans outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $ 8.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $ 504.4 million of capacity and $ 496.4 million available for borrowing under its credit facility. As of December 31, 2023, the Company had a total of $ 126.4 million of revolving loans, with an interest rate of 7.21 %, outstanding on its credit facility. As of June 30, 2024 , the Company was in compliance with all financial covenants under the Credit Agreement.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes The effective income tax rates were 26.3 % and 23.8 % for the three months ended June 30, 2024 and 2023, respectively. The effective income tax rates were 26.0 % and 23.0 % for the six months ended June 30, 2024 and 2023 , respectively. The difference between our federal statutory rate of 21 % and our effective income tax rates is principally due to the inclusion of state taxes and non-deductible compensation, partially offset by the use of federal employment tax credits.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Legal Proceedings From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Segment Information	12. Segment Information Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision makers, to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy. The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements. Segment assets are not reviewed by the Company’s chief operating decision maker function and therefore are not disclosed below. Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management. For the Three Months Ended June 30, 2024 (Amounts in Thousands) Personal Care Hospice Home Health Total Net service revenues $ 212,817 $ 56,030 $ 18,075 $ 286,922 Cost of services revenues 152,755 29,730 11,279 193,764 Gross profit 60,062 26,300 6,796 93,158 General and administrative expenses 16,973 13,466 4,572 35,011 Segment operating income $ 43,089 $ 12,834 $ 2,224 $ 58,147 For the Three Months Ended June 30, 2023 (Amounts in Thousands) Personal Care Hospice Home Health Total Net service revenues $ 198,314 $ 50,210 $ 11,456 $ 259,980 Cost of services revenues 143,972 26,606 7,084 177,662 Gross profit 54,342 23,604 4,372 82,318 General and administrative expenses 16,267 12,768 2,641 31,676 Segment operating income $ 38,075 $ 10,836 $ 1,731 $ 50,642 For the Three Months Ended June 30, 2024 2023 (Amounts in Thousands) Segment reconciliation: Total segment operating income $ 58,147 $ 50,642 Items not allocated at segment level: Other general and administrative expenses 28,565 25,721 Depreciation and amortization 3,401 3,382 Interest income ( 474 ) ( 291 ) Interest expense 2,114 2,331 Income before income taxes $ 24,541 $ 19,499 For the Six Months Ended June 30, 2024 (Amounts in Thousands) Personal Care Hospice Home Health Total Net service revenues $ 420,820 $ 111,893 $ 34,955 $ 567,668 Cost of services revenues 305,291 58,697 22,345 386,333 Gross profit 115,529 53,196 12,610 181,335 General and administrative expenses 32,418 26,905 9,109 68,432 Segment operating income $ 83,111 $ 26,291 $ 3,501 $ 112,903 For the Six Months Ended June 30, 2023 (Amounts in Thousands) Personal Care Hospice Home Health Total Net service revenues $ 388,346 $ 99,292 $ 23,941 $ 511,579 Cost of services revenues 282,355 53,873 14,618 350,846 Gross profit 105,991 45,419 9,323 160,733 General and administrative expenses 32,202 25,783 5,521 63,506 Segment operating income $ 73,789 $ 19,636 $ 3,802 $ 97,227 For the Six Months Ended June 30, 2024 2023 (Amounts in Thousands) Segment reconciliation: Total segment operating income $ 112,903 $ 97,227 Items not allocated at segment level: Other general and administrative expenses 56,207 50,251 Depreciation and amortization 6,870 6,829 Interest income ( 897 ) ( 397 ) Interest expense 4,872 4,792 Income before income taxes $ 45,851 $ 35,752

Significant Payors

Significant Payors	6 Months Ended
	Jun. 30, 2024
Significant Payors [Abstract]
Significant Payors	13. Significant Payors The Company’s revenue by payor type was as follows: Personal Care Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of State, local and other governmental programs $ 113,002 53.1 % $ 100,399 50.6 % $ 220,756 52.5 % $ 195,721 50.4 % Managed care organizations 94,135 44.2 91,276 46.0 188,411 44.8 179,176 46.1 Private pay 3,689 1.7 4,137 2.2 7,595 1.8 8,363 2.2 Commercial insurance 1,467 0.7 1,637 0.8 2,953 0.7 3,306 0.9 Other 524 0.3 865 0.4 1,105 0.2 1,780 0.4 Total personal care segment net service revenues $ 212,817 100.0 % $ 198,314 100.0 % $ 420,820 100.0 % $ 388,346 100.0 % Hospice Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Medicare $ 51,122 91.2 % $ 45,566 90.7 % $ 101,774 91.0 % $ 90,122 90.8 % Commercial insurance 2,844 5.1 2,726 5.4 5,978 5.3 5,273 5.3 Managed care organizations 1,880 3.4 1,567 3.1 3,697 3.3 3,214 3.2 Other 184 0.3 351 0.8 444 0.4 684 0.7 Total hospice segment net service revenues $ 56,030 100.0 % $ 50,210 100.0 % $ 111,893 100.0 % $ 99,293 100.0 % Home Health Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Medicare $ 12,517 69.3 % $ 8,716 76.1 % $ 24,180 69.2 % $ 17,988 75.1 % Managed care organizations 4,676 25.9 2,251 19.6 9,076 26.0 4,789 20.0 Other 882 4.8 489 4.3 1,699 4.8 1,164 4.9 Total home health segment net service revenues $ 18,075 100.0 % $ 11,456 100.0 % $ 34,955 100.0 % $ 23,941 100.0 % During the three and six months ended June 30, 2024 and 2023 , the Company derived a significant amount of its revenue from its operations in Illinois, New Mexico, New York, Ohio and Tennessee. The percentages of segment revenue for each of these significant states were as follows: Personal Care Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Illinois $ 110,774 52.1 % $ 103,864 52.4 % $ 218,349 51.9 % $ 202,279 52.1 % New Mexico 28,644 13.5 27,907 14.1 57,611 13.7 56,381 14.5 New York (1) 23,299 10.9 23,841 12.0 46,833 11.1 45,727 11.8 All other states 50,100 23.5 42,702 21.5 98,027 23.3 83,959 21.6 Total personal care segment net service revenues $ 212,817 100.0 % $ 198,314 100.0 % $ 420,820 100.0 % $ 388,346 100.0 % (1) The selection process for CDPAP fiscal intermediaries has changed significantly in recent years and the program continues to be an area of focus for New York governmental authorities. The Company was not one of the entities selected through an RFO process to competitively procure fiscal intermediaries that was initiated in 2019 and, in November 2022, decided to suspend materially all of its new fee-for-service patient admissions through County Social Service Departments. The Company received a contract award in June 2023 and resumed new fee-for-service patient admissions. However, the New York fiscal year 2025 budget will replace the CDPAP fiscal intermediaries with a single statewide fiscal intermediary with a stated deadline of April 1, 2025. All service providers seeking to offer services under CDPAP will be required to contract with the statewide fiscal intermediary or its contractors in order to offer services. The Company does not believe it is likely to be selected as the single statewide fiscal intermediary, and it is difficult to predict the details of the implementation of these modifications and their final timeline and, thus, their impact on the Company’s business and operations. As a result of the changes and uncertainty in the state, the Company determined that its New York personal care operations no longer fit its growth strategy and reached an agreement to divest these operations. See Note 4 to the Notes to Unaudited Condensed Consolidated Financial Statements, Acquisition and Divestiture , for additional details regarding our divestiture. Hospice Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Ohio $ 20,633 36.8 % $ 19,332 38.5 % $ 40,869 36.5 % $ 37,783 38.1 % Illinois 13,003 23.2 11,606 23.1 25,255 22.6 23,087 23.3 New Mexico 6,895 12.3 6,540 13.0 14,410 12.9 13,026 13.1 All other states 15,499 27.7 12,732 25.4 31,359 28.0 25,397 25.5 Total hospice segment net service revenues $ 56,030 100.0 % $ 50,210 100.0 % $ 111,893 100.0 % $ 99,293 100.0 % Home Health Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of New Mexico $ 8,300 45.9 % $ 8,093 70.6 % $ 16,077 46.0 % $ 17,209 71.9 % Illinois 3,042 16.8 3,363 29.4 5,984 17.1 6,732 28.1 Tennessee 6,733 37.3 — — 12,894 36.9 — — Total home health segment net service revenues $ 18,075 100.0 % $ 11,456 100.0 % $ 34,955 100.0 % $ 23,941 100.0 % A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 38.6 %, and 40.0 % of our net service revenues for the three months ended June 30, 2024, and 2023, respectively, and accounted for 38.5 % and 39.5 % of our net service revenues for the six months ended June 30, 2024 and 2023, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 21.1 % and 21.5 % of the Company’s net service revenues for the three months ended June 30, 2024 and 2023, respectively, and accounted for 20.9 % and 21.5 % of the Company’s net service revenues for the six months ended June 30, 2024 and 2023, respectively. The related receivables due from the Illinois Department on Aging represented 21.7 % and 20.7 % of the Company’s net accounts receivable at June 30, 2024 and December 31, 2023 , respectively.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2023 has been derived from the Company’s audited financial statements for the year ended December 31, 2023 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2023 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.
Principles of Consolidation	Principles of Consolidation These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Estimates	Estimates The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles in business combinations and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.
Computation of Weighted Average Shares	Computation of Weighted Average Shares The following table sets forth the computation of basic and diluted common shares: For the Three Months Ended June 30, For the Six Months Ended June 30, (Amounts in thousands) (Amounts in thousands) 2024 2023 2024 2023 Weighted average number of shares outstanding for basic per share 16,177 16,002 16,120 15,975 Effect of dilutive potential shares: Stock options 251 237 239 245 Restricted stock awards 70 44 90 84 Adjusted weighted average shares outstanding for diluted per share 16,498 16,283 16,449 16,304 Anti-dilutive shares: Stock options 19 61 42 61 Restricted stock awards 8 77 8 1
Recently Issued and Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. The ASU was adopted prospectively on January 1, 2023 . The additional disclosures required did no t have a material impact on our consolidated financial statements. Recently Issued Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures , which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Annual disclosures are required for fiscal years beginning after December 15, 2023 and interim disclosures are required for periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. These requirements will result in expanded disclosures. In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures , which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied prospectively or retrospectively, and allows for early adoption . These requirements are no t expected to have an impact on the Company's financial statements and will expand income tax disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Computation of Basic and Diluted Common Shares	The following table sets forth the computation of basic and diluted common shares: For the Three Months Ended June 30, For the Six Months Ended June 30, (Amounts in thousands) (Amounts in thousands) 2024 2023 2024 2023 Weighted average number of shares outstanding for basic per share 16,177 16,002 16,120 15,975 Effect of dilutive potential shares: Stock options 251 237 239 245 Restricted stock awards 70 44 90 84 Adjusted weighted average shares outstanding for diluted per share 16,498 16,283 16,449 16,304 Anti-dilutive shares: Stock options 19 61 42 61 Restricted stock awards 8 77 8 1

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Amounts Reported in Unaudited and Audited Condensed Consolidated Balance Sheets for Operating Leases	Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows: June 30, 2024 December 31, 2023 (Amounts in Thousands) Operating lease assets, net $ 44,145 $ 45,433 Short-term operating lease liabilities (in accrued expenses ) 11,224 11,339 Long-term operating lease liabilities 38,359 39,711 Total operating lease liabilities $ 49,583 $ 51,050
Components of Lease Costs Reported in General and Administrative Expenses in Unaudited Condensed Consolidated Statements of Income	Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows: For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Operating lease costs $ 3,373 $ 3,292 $ 6,669 $ 6,334 Short-term lease costs 179 284 380 700 Total lease costs 3,552 3,576 7,049 7,034 Less: sublease income ( 491 ) ( 700 ) ( 1,089 ) ( 1,399 ) Total lease costs, net $ 3,061 $ 2,876 $ 5,960 $ 5,635
Schedule of Weighted Average Remaining Lease Terms and Discount Rates	Weighted average remaining lease terms and discount rates were as follows: June 30, 2024 December 31, 2023 Operating leases: Weighted average remaining lease term (years) 5.98 6.26 Weighted average discount rate 5.80 % 5.47 %
Summary of Remaining Operating Lease Payments	Remaining operating lease payments as of June 30, 2024 were as follows: Operating Leases (Amounts in Thousands) Due in the 12-month period ended June 30, 2025 $ 7,368 2026 11,955 2027 9,534 2028 6,974 2029 5,707 Thereafter 17,799 Total future minimum rental commitments 59,337 Less: Imputed interest ( 9,754 ) Total lease liabilities $ 49,583
Supplemental Cash Flows Information	For the Six Months Ended June 30, (Amounts in Thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 7,224 $ 7,010 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 4,509 $ 14,415

Acquisitions and Divestiture (T

Acquisitions and Divestiture (Tables)	6 Months Ended
	Jun. 30, 2024
Business Combinations [Abstract]
Carrying amounts of the assets and liabilities	The carrying amounts of the assets and liabilities associated with our New York personal care operations included in our Unaudited Condensed Consolidated Balance Sheets as of June 30, 2024 were as follows (amounts in thousands): June 30, 2024 Assets Current assets Accounts receivable, net of allowances $ 7,712 Prepaid expenses and other current assets 3 Total current assets 7,715 Property and equipment, net of accumulated depreciation and amortization 34 Other assets Goodwill 3,801 Intangibles, net of accumulated amortization 4,841 Operating lease assets, net 3,727 Total other assets 12,369 Total assets $ 20,118 Liabilities Current liabilities Accounts payable $ 6,340 Accrued payroll 3,531 Accrued expenses 753 Operating lease liabilities, current portion 790 Total current liabilities 11,414 Long-term liabilities Other long-term liabilities 2,829 Total liabilities $ 14,243

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Goodwill and Related Adjustments	A summary of the goodwill and related adjustments is provided below: Hospice Personal Care Home Health Total (Amounts in Thousands) Goodwill as of December 31, 2023 $ 432,799 $ 153,276 $ 76,920 $ 662,995 Additions for acquisitions — 400 — 400 Adjustments to previously recorded goodwill 38 — 418 456 Goodwill as of June 30, 2024 $ 432,837 $ 153,676 $ 77,338 $ 663,851
Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset	The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following: June 30, 2024 December 31, 2023 (Amounts in Thousands) (Amounts in Thousands) Estimated Useful Life Gross carrying value Accumulated amortization Net carrying value Gross carrying value Accumulated amortization Net carrying value Customer and referral relationships 5 - 10 years $ 44,672 $ ( 40,248 ) $ 4,424 $ 44,672 $ ( 39,566 ) $ 5,106 Trade names and trademarks 1 - 20 years 59,566 ( 25,360 ) 34,206 59,566 ( 23,857 ) 35,709 Non-competition agreement 3 - 5 years 6,785 ( 6,009 ) 776 6,785 ( 5,601 ) 1,184 State Licenses 6 - 10 years 12,671 ( 10,007 ) 2,664 12,671 ( 9,015 ) 3,656 State Licenses Indefinite 46,328 — 46,328 46,328 — 46,328 Total intangible assets $ 170,022 $ ( 81,624 ) $ 88,398 $ 170,022 $ ( 78,039 ) $ 91,983

Details of Certain Balance Sh_2

Details of Certain Balance Sheet Accounts (Tables)	6 Months Ended
	Jun. 30, 2024
Details Of Certain Balance Sheet Accounts [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following: June 30, 2024 December 31, 2023 (Amounts in Thousands) Prepaid payroll $ — $ 8,735 Prepaid workers' compensation and liability insurance 4,411 3,696 Prepaid licensing fees 4,874 4,481 Workers' compensation insurance receivable 623 577 Other 2,580 2,225 Total prepaid expenses and other current assets $ 12,488 $ 19,714
Schedule of Accrued Expenses	Accrued expenses consisted of the following: June 30, 2024 December 31, 2023 (Amounts in Thousands) Accrued health benefits 7,061 7,400 Payor advances (1) — 1,218 Accrued professional fees 8,389 7,304 Accrued payroll and other taxes 6,256 8,572 Other (2) 13,927 8,742 Total accrued expenses $ 35,633 $ 33,236 (1) Represents the deferred portion of payments received from payors for COVID-19 reimbursements which was recognized as we incurred specific COVID-19 related expenses (including expenses related to securing and maintaining adequate personnel). (2) Includes a $ 4.6 million initial payment received for the New York Asset Sale as of June 30, 2024 .

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Jun. 30, 2024
Long-Term Debt, Unclassified [Abstract]
Schedule of Long-Term Debt	Long-term debt consisted of the following: June 30, 2024 December 31, 2023 (Amounts in Thousands) Revolving loan under the credit facility $ — $ 126,353 Less unamortized issuance costs (1) — ( 2,221 ) Long-term debt $ — $ 124,132 (1) As of June 30, 2024, unamortized issuance costs $ 1.8 million are recorded in Other long-term assets on the Company ’ s Unaudited Condensed Consolidated Balance Sheets.

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Summary of Segment Information	For the Three Months Ended June 30, 2024 (Amounts in Thousands) Personal Care Hospice Home Health Total Net service revenues $ 212,817 $ 56,030 $ 18,075 $ 286,922 Cost of services revenues 152,755 29,730 11,279 193,764 Gross profit 60,062 26,300 6,796 93,158 General and administrative expenses 16,973 13,466 4,572 35,011 Segment operating income $ 43,089 $ 12,834 $ 2,224 $ 58,147 For the Three Months Ended June 30, 2023 (Amounts in Thousands) Personal Care Hospice Home Health Total Net service revenues $ 198,314 $ 50,210 $ 11,456 $ 259,980 Cost of services revenues 143,972 26,606 7,084 177,662 Gross profit 54,342 23,604 4,372 82,318 General and administrative expenses 16,267 12,768 2,641 31,676 Segment operating income $ 38,075 $ 10,836 $ 1,731 $ 50,642 For the Three Months Ended June 30, 2024 2023 (Amounts in Thousands) Segment reconciliation: Total segment operating income $ 58,147 $ 50,642 Items not allocated at segment level: Other general and administrative expenses 28,565 25,721 Depreciation and amortization 3,401 3,382 Interest income ( 474 ) ( 291 ) Interest expense 2,114 2,331 Income before income taxes $ 24,541 $ 19,499 For the Six Months Ended June 30, 2024 (Amounts in Thousands) Personal Care Hospice Home Health Total Net service revenues $ 420,820 $ 111,893 $ 34,955 $ 567,668 Cost of services revenues 305,291 58,697 22,345 386,333 Gross profit 115,529 53,196 12,610 181,335 General and administrative expenses 32,418 26,905 9,109 68,432 Segment operating income $ 83,111 $ 26,291 $ 3,501 $ 112,903 For the Six Months Ended June 30, 2023 (Amounts in Thousands) Personal Care Hospice Home Health Total Net service revenues $ 388,346 $ 99,292 $ 23,941 $ 511,579 Cost of services revenues 282,355 53,873 14,618 350,846 Gross profit 105,991 45,419 9,323 160,733 General and administrative expenses 32,202 25,783 5,521 63,506 Segment operating income $ 73,789 $ 19,636 $ 3,802 $ 97,227 For the Six Months Ended June 30, 2024 2023 (Amounts in Thousands) Segment reconciliation: Total segment operating income $ 112,903 $ 97,227 Items not allocated at segment level: Other general and administrative expenses 56,207 50,251 Depreciation and amortization 6,870 6,829 Interest income ( 897 ) ( 397 ) Interest expense 4,872 4,792 Income before income taxes $ 45,851 $ 35,752

Significant Payors (Tables)

Significant Payors (Tables)	6 Months Ended
	Jun. 30, 2024
Significant Payors [Abstract]
Schedule of Revenue by Payor Type	The Company’s revenue by payor type was as follows: Personal Care Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of State, local and other governmental programs $ 113,002 53.1 % $ 100,399 50.6 % $ 220,756 52.5 % $ 195,721 50.4 % Managed care organizations 94,135 44.2 91,276 46.0 188,411 44.8 179,176 46.1 Private pay 3,689 1.7 4,137 2.2 7,595 1.8 8,363 2.2 Commercial insurance 1,467 0.7 1,637 0.8 2,953 0.7 3,306 0.9 Other 524 0.3 865 0.4 1,105 0.2 1,780 0.4 Total personal care segment net service revenues $ 212,817 100.0 % $ 198,314 100.0 % $ 420,820 100.0 % $ 388,346 100.0 % Hospice Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Medicare $ 51,122 91.2 % $ 45,566 90.7 % $ 101,774 91.0 % $ 90,122 90.8 % Commercial insurance 2,844 5.1 2,726 5.4 5,978 5.3 5,273 5.3 Managed care organizations 1,880 3.4 1,567 3.1 3,697 3.3 3,214 3.2 Other 184 0.3 351 0.8 444 0.4 684 0.7 Total hospice segment net service revenues $ 56,030 100.0 % $ 50,210 100.0 % $ 111,893 100.0 % $ 99,293 100.0 % Home Health Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Medicare $ 12,517 69.3 % $ 8,716 76.1 % $ 24,180 69.2 % $ 17,988 75.1 % Managed care organizations 4,676 25.9 2,251 19.6 9,076 26.0 4,789 20.0 Other 882 4.8 489 4.3 1,699 4.8 1,164 4.9 Total home health segment net service revenues $ 18,075 100.0 % $ 11,456 100.0 % $ 34,955 100.0 % $ 23,941 100.0 %
Schedule of Revenue by Geographic Location	The percentages of segment revenue for each of these significant states were as follows: Personal Care Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Illinois $ 110,774 52.1 % $ 103,864 52.4 % $ 218,349 51.9 % $ 202,279 52.1 % New Mexico 28,644 13.5 27,907 14.1 57,611 13.7 56,381 14.5 New York (1) 23,299 10.9 23,841 12.0 46,833 11.1 45,727 11.8 All other states 50,100 23.5 42,702 21.5 98,027 23.3 83,959 21.6 Total personal care segment net service revenues $ 212,817 100.0 % $ 198,314 100.0 % $ 420,820 100.0 % $ 388,346 100.0 % (1) The selection process for CDPAP fiscal intermediaries has changed significantly in recent years and the program continues to be an area of focus for New York governmental authorities. The Company was not one of the entities selected through an RFO process to competitively procure fiscal intermediaries that was initiated in 2019 and, in November 2022, decided to suspend materially all of its new fee-for-service patient admissions through County Social Service Departments. The Company received a contract award in June 2023 and resumed new fee-for-service patient admissions. However, the New York fiscal year 2025 budget will replace the CDPAP fiscal intermediaries with a single statewide fiscal intermediary with a stated deadline of April 1, 2025. All service providers seeking to offer services under CDPAP will be required to contract with the statewide fiscal intermediary or its contractors in order to offer services. The Company does not believe it is likely to be selected as the single statewide fiscal intermediary, and it is difficult to predict the details of the implementation of these modifications and their final timeline and, thus, their impact on the Company’s business and operations. As a result of the changes and uncertainty in the state, the Company determined that its New York personal care operations no longer fit its growth strategy and reached an agreement to divest these operations. See Note 4 to the Notes to Unaudited Condensed Consolidated Financial Statements, Acquisition and Divestiture , for additional details regarding our divestiture. Hospice Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of Ohio $ 20,633 36.8 % $ 19,332 38.5 % $ 40,869 36.5 % $ 37,783 38.1 % Illinois 13,003 23.2 11,606 23.1 25,255 22.6 23,087 23.3 New Mexico 6,895 12.3 6,540 13.0 14,410 12.9 13,026 13.1 All other states 15,499 27.7 12,732 25.4 31,359 28.0 25,397 25.5 Total hospice segment net service revenues $ 56,030 100.0 % $ 50,210 100.0 % $ 111,893 100.0 % $ 99,293 100.0 % Home Health Segment For the Three Months Ended June 30, For the Six Months Ended June 30, 2024 2023 2024 2023 Amount % of Amount % of Amount % of Amount % of New Mexico $ 8,300 45.9 % $ 8,093 70.6 % $ 16,077 46.0 % $ 17,209 71.9 % Illinois 3,042 16.8 3,363 29.4 5,984 17.1 6,732 28.1 Tennessee 6,733 37.3 — — 12,894 36.9 — — Total home health segment net service revenues $ 18,075 100.0 % $ 11,456 100.0 % $ 34,955 100.0 % $ 23,941 100.0 %

Nature of Operations, Consoli_2

Nature of Operations, Consolidation, and Presentation of Financial Statements (Narrative) (Details)	6 Months Ended
	Jun. 30, 2024 Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	3

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Computation of Basic and Diluted Common Shares) (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Summary Of Significant Accounting Policies [Line Items]
Weighted average number of shares outstanding for basic per share calculation	16,177	16,002	16,120	15,975
Effect of dilutive potential shares:
Adjusted weighted average shares outstanding for diluted per share calculation	16,498	16,283	16,449	16,304
Employee Stock Option
Effect of dilutive potential shares:
Effect of dilutive potential shares	251	237	239	245
Anti-dilutive shares:
Anti-dilutive shares	19	61	42	61
Restricted Stock Awards [Member]
Effect of dilutive potential shares:
Effect of dilutive potential shares	70	44	90	84
Anti-dilutive shares:
Anti-dilutive shares	8	77	8	1

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Narrative) (Details)	Jun. 30, 2024
ASU 2021-08 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted	true
Change in accounting principle, accounting standards update, immaterial effect	true
Change in accounting principle, accounting standards update, adoption date	Jan. 01, 2023
Accounting Standards Update 2023-07 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, early adoption	true
Accounting Standards Update 2023-09 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, immaterial effect	true
Change in accounting principle, accounting standards update, early adoption	true

Leases (Amounts Reported in Una

Leases (Amounts Reported in Unaudited and Audited Condensed Consolidated Balance Sheets for Operating Leases) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Leases [Abstract]
Operating lease assets, net	$ 44,145	$ 45,433
Short-term operating lease liabilities (in accrued expenses)	$ 11,224	$ 11,339
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses	Accrued expenses
Long-term operating lease liabilities	$ 38,359	$ 39,711
Total operating lease liabilities	$ 49,583	$ 51,050

Leases (Components of Lease Cos

Leases (Components of Lease Costs Reported in General and Administrative Expenses in Unaudited Condensed Consolidated Statements of Income) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Leases [Abstract]
Operating lease costs	$ 3,373	$ 3,292	$ 6,669	$ 6,334
Short-term lease costs	179	284	380	700
Total lease costs	3,552	3,576	7,049	7,034
Less: sublease income	(491)	(700)	(1,089)	(1,399)
Total lease costs, net	$ 3,061	$ 2,876	$ 5,960	$ 5,635

Leases (Schedule of Weighted Av

Leases (Schedule of Weighted Average Remaining Lease Terms and Discount Rates) (Details)	Jun. 30, 2024	Dec. 31, 2023
Leases [Abstract]
Weighted average remaining lease term (years)	5 years 11 months 23 days	6 years 3 months 3 days
Weighted average discount rate	5.80%	5.47%

Leases (Summary of Remaining Op

Leases (Summary of Remaining Operating Lease Payments) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Leases [Abstract]
2025	$ 7,368
2026	11,955
2027	9,534
2028	6,974
2029	5,707
Thereafter	17,799
Total future minimum rental commitments	59,337
Less: Imputed interest	(9,754)
Total lease liabilities	$ 49,583	$ 51,050

Leases (Supplemental Cash Flows

Leases (Supplemental Cash Flows Information) (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 7,224	$ 7,010
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 4,509	$ 14,415

Public Offering (Narrative) (De

Public Offering (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended	6 Months Ended
	Jun. 28, 2024	Jun. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Class of Stock [Line Items]
Common stock, par value		$ 0.001	$ 0.001		$ 0.001
Proceeds from Issuance of Common Stock			$ 175,578
Repayment of indebtedness outstanding under credit facility			$ 126,353	$ 53,500
Common Stock [Member]
Class of Stock [Line Items]
Shares issued in public offering, net of offering costs, Shares		1,725,000	1,725,000
Offering price	$ 108
Public Offering | Common Stock [Member]
Class of Stock [Line Items]
Shares issued in public offering, net of offering costs, Shares	1,725,000
Common stock, par value	$ 0.001
Proceeds from Issuance of Common Stock	$ 175,600
Paid in capital	175,600
Underwriting discounts and estimated offering expenses	10,700
Public Offering | Common Stock [Member] | Revolving Credit Loan
Class of Stock [Line Items]
Repayment of indebtedness outstanding under credit facility	$ 81,400
Allotment | Common Stock [Member]
Class of Stock [Line Items]
Shares issued in public offering, net of offering costs, Shares	225,000

Acquisition and Divestiture - (

Acquisition and Divestiture - (Schedule of carrying amounts of the assets and liabilities) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets
Accounts receivable, net of allowances	$ 109,195	$ 115,499
Prepaid expenses and other current assets	12,488	19,714
Total current assets	294,988	200,004
Property and equipment, net of accumulated depreciation and amortization	23,381	24,011
Other assets
Goodwill	663,851	662,995
Intangibles, net of accumulated amortization	88,398	91,983
Operating lease assets, net	44,145	45,433
Total other assets	798,185	800,411
Total assets	1,116,554	1,024,426
Current liabilities
Accounts payable	20,188	26,183
Accrued payroll	55,102	56,551
Accrued expenses	35,633	33,236
Operating lease liabilities, current portion	11,224	11,339
Total current liabilities	147,532	145,117
Long-term liabilities
Other long-term liabilities	9,008	8,772
Total liabilities	194,899	$ 317,732
New york personal care operations [Member]
Current assets
Accounts receivable, net of allowances	7,712
Prepaid expenses and other current assets	3
Total current assets	7,715
Property and equipment, net of accumulated depreciation and amortization	34
Other assets
Goodwill	3,801
Intangibles, net of accumulated amortization	4,841
Operating lease assets, net	3,727
Total other assets	12,369
Total assets	20,118
Current liabilities
Accounts payable	6,340
Accrued payroll	3,531
Accrued expenses	753
Operating lease liabilities, current portion	790
Total current liabilities	11,414
Long-term liabilities
Other long-term liabilities	2,829
Total liabilities	$ 14,243

Acquisition and Divestiture (Na

Acquisition and Divestiture (Narrative) (Details) $ in Thousands		3 Months Ended	6 Months Ended
	Jun. 08, 2024 USD ($) Patient	Jun. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	May 21, 2024 USD ($)
Business Acquisition [Line Items]
Total purchase price for business acquisition			$ 400	$ 940
Initial payment received			4,600
Asset Purchase Agreement
Business Acquisition [Line Items]
Management fee		$ 4,600	$ 4,600
Initial payment received		$ 700
Maximum [Member] | Asset Purchase Agreement
Business Acquisition [Line Items]
Purchase price					$ 23,000
Gentiva [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition	$ 350,000
Number of Patients Served per Day | Patient	16,000

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Summary of Goodwill and Related Adjustments) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Goodwill [Line Items]
Goodwill, at Beginning of Period	$ 662,995
Additions for acquisitions	400
Adjustments to previously recorded goodwill	456
Goodwill, at End of Period	663,851
Hospice [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	432,799
Adjustments to previously recorded goodwill	38
Goodwill, at End of Period	432,837
Personal Care [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	153,276
Additions for acquisitions	400
Goodwill, at End of Period	153,676
Home Health [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	76,920
Adjustments to previously recorded goodwill	418
Goodwill, at End of Period	$ 77,338

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Mar. 09, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Goodwill [Line Items]
Goodwill		$ 663,851		$ 663,851		$ 662,995
Amortization expense		$ 1,800	$ 1,700	3,600	$ 3,500
Total purchase price for business acquisition				$ 400	$ 940
Weighted average remaining useful lives of identifiable intangible assets		10 years 1 month 6 days		10 years 1 month 6 days
Minimum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives		1 year		1 year
Minimum [Member] | Customer and Referral Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives		5 years		5 years
Maximum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives		20 years		20 years
Maximum [Member] | Customer and Referral Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives		10 years		10 years
Personal Care [Member]
Goodwill [Line Items]
Goodwill		$ 153,676		$ 153,676		$ 153,276
Upstate Home Care Solutions [Member]
Goodwill [Line Items]
Total purchase price for business acquisition	$ 400
Upstate Home Care Solutions [Member] | Personal Care [Member]
Goodwill [Line Items]
Goodwill		$ 400		$ 400

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Intangible assets subject to amortization:
Accumulated amortization	$ (81,624)	$ (78,039)
Total intangible assets, Gross carrying value	170,022	170,022
Total intangible assets, Net carrying value	$ 88,398	91,983
Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	1 year
Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	20 years
Customer and Referral Relationships [Member]
Intangible assets subject to amortization:
Gross carrying value	$ 44,672	44,672
Accumulated amortization	(40,248)	(39,566)
Net carrying value	$ 4,424	5,106
Customer and Referral Relationships [Member] | Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	5 years
Customer and Referral Relationships [Member] | Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	10 years
Trade Names and Trademarks [Member]
Intangible assets subject to amortization:
Gross carrying value	$ 59,566	59,566
Accumulated amortization	(25,360)	(23,857)
Net carrying value	$ 34,206	35,709
Trade Names and Trademarks [Member] | Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	1 year
Trade Names and Trademarks [Member] | Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	20 years
Non-competition Agreements [Member]
Intangible assets subject to amortization:
Gross carrying value	$ 6,785	6,785
Accumulated amortization	(6,009)	(5,601)
Net carrying value	$ 776	1,184
Non-competition Agreements [Member] | Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	3 years
Non-competition Agreements [Member] | Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	5 years
State Licenses [Member]
Intangible assets subject to amortization:
Gross carrying value	$ 12,671	12,671
Accumulated amortization	(10,007)	(9,015)
Net carrying value	2,664	3,656
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$ 46,328	$ 46,328
State Licenses [Member] | Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	6 years
State Licenses [Member] | Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	10 years

Details of Certain Balance Sh_3

Details of Certain Balance Sheet Accounts (Schedule of Prepaid Expenses and Other Current Assets) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Details Of Certain Balance Sheet Accounts [Abstract]
Prepaid payroll		$ 8,735
Prepaid workers' compensation and liability insurance	$ 4,411	3,696
Prepaid licensing fees	4,874	4,481
Workers' compensation insurance receivable	623	577
Other	2,580	2,225
Total prepaid expenses and other current assets	$ 12,488	$ 19,714

Details of Certain Balance Sh_4

Details of Certain Balance Sheet Accounts (Schedule of Accrued Expenses) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Details Of Certain Balance Sheet Accounts [Abstract]
Accrued health benefits	$ 7,061	$ 7,400
Payor advances		1,218
Accrued professional fees	8,389	7,304
Accrued payroll and other taxes	6,256	8,572
Other	13,927	8,742
Total accrued expenses	$ 35,633	$ 33,236

Details of Certain Balance Sh_5

Details of Certain Balance Sheet Accounts - Schedule of Accrued Expenses (Parenthetical) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Details Of Certain Balance Sheet Accounts [Abstract]
Initial payment received	$ 4,600

Government Actions to Mitigat_2

Government Actions to Mitigate COVID-19's Impact (Narrative) (Details) - USD ($)			1 Months Ended	3 Months Ended		6 Months Ended	12 Months Ended
	Jul. 01, 2022	Mar. 11, 2021	Jan. 31, 2022	Jun. 30, 2024	Jun. 30, 2022	Jun. 30, 2024	Mar. 31, 2022
CARES Act [Member]
Government Assistance [Line Items]
Percentage of reduced payments to Medicare providers	2%					2%
Reduction percentage on sequestration adjustment					1%
ARPA [Member]
Government Assistance [Line Items]
Relief funding to mitigate fiscal effects of COVID-19		$ 350,000,000,000
percentage point increase in federal matching funds							10%
Deferred portion of spending plans				$ 13,000,000		$ 13,000,000
Aggregate principal amount of grants received				12,200,000		12,200,000
Fund distributed to primarily for caregivers and retention efforts				2,500,000		4,900,000
Revenues				0		0
Cost of revenue				0		0
Aggregate funding amount				$ 2,000,000		$ 12,200,000
PAYGO Act [Member]
Government Assistance [Line Items]
Percentage of additional payment reduction			4%

Long-Term Debt (Schedule of Lon

Long-Term Debt (Schedule of Long-Term Debt) (Details) $ in Thousands	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Less unamortized issuance costs	$ (2,221)
Long-term debt	124,132
Revolving Credit Loan [Member] | Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt gross	$ 126,353

Long-Term Debt - Schedule of Lo

Long-Term Debt - Schedule of Long-Term Debt (Parenthetical) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Unamortized issuance costs		$ 2,221
Other Long-term Assets [Member]
Debt Instrument [Line Items]
Unamortized issuance costs	$ 1,800

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - Credit Agreement [Member] - USD ($)		6 Months Ended
	Apr. 26, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Debt Instrument [Line Items]
Line of credit outstanding amount		$ 504,400,000
Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		496,400,000
Debt instrument, maturity date	Jul. 30, 2026
Debt instrument variable interest rate margin	1%
Debt instrument total net leverage ratio	4.25%
Line of credit outstanding amount		8,000,000
Capital One, National Association [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument total net leverage ratio	3.75%
Capital One, National Association [Member] | Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	0.50%
Capital One, National Association [Member] | One-Month Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	0.10%
Capital One, National Association [Member] | One-Month Secured Overnight Financing Rate (SOFR) [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	0%
Capital One, National Association [Member] | Based On Applicable Senior Leverage Ratio [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	0.75%
Capital One, National Association [Member] | Based On Applicable Senior Leverage Ratio [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	1.50%
Capital One, National Association [Member] | Based On Applicable Leverage Ratio [Member] | Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	1.75%
Capital One, National Association [Member] | Based On Applicable Leverage Ratio [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	2.50%
Capital One, National Association [Member] | Restriction on Dividends [Member] | Maximum [Member]
Debt Instrument [Line Items]
Aggregate amount of dividends and distributions		7,500,000
Revolving Credit Loan [Member] | Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		600,000,000
Proceeds from line of credit		0	$ 0
Repayments of line of credit			$ 53,500,000
Line of credit outstanding amount		$ 0		$ 126,400,000
Debt instrument stated interest rate				7.21%
Revolving Credit Loan [Member] | Capital One, National Association [Member] | Minimum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility		0.20%
Revolving Credit Loan [Member] | Capital One, National Association [Member] | Maximum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility		0.35%
Incremental Loan Facility [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		$ 125,000,000

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	26.30%	23.80%	26%	23%
Effective income tax, federal statutory rate			21%

Segment Information (Narrative)

Segment Information (Narrative) (Details)	6 Months Ended
	Jun. 30, 2024 Segment
Segment Reporting [Abstract]
Number of business segments	3

Segment Information (Summary of

Segment Information (Summary of Segment Information) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting Information [Line Items]
Net service revenues	$ 286,922	$ 259,980	$ 567,668	$ 511,579
Cost of services revenues	193,764	177,662	386,333	350,846
Gross profit	93,158	82,318	181,335	160,733
General and administrative expenses	63,576	57,397	124,639	113,757
Operating income	26,181	21,539	49,826	40,147
Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	35,011	31,676	68,432	63,506
Operating income	58,147	50,642	112,903	97,227
Personal Care [Member]
Segment Reporting Information [Line Items]
Net service revenues	212,817	198,314	420,820	388,346
Cost of services revenues	152,755	143,972	305,291	282,355
Gross profit	60,062	54,342	115,529	105,991
Personal Care [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	16,973	16,267	32,418	32,202
Operating income	43,089	38,075	83,111	73,789
Hospice [Member]
Segment Reporting Information [Line Items]
Net service revenues	56,030	50,210	111,893	99,292
Cost of services revenues	29,730	26,606	58,697	53,873
Gross profit	26,300	23,604	53,196	45,419
Hospice [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	13,466	12,768	26,905	25,783
Operating income	12,834	10,836	26,291	19,636
Home Health [Member]
Segment Reporting Information [Line Items]
Net service revenues	18,075	11,456	34,955	23,941
Cost of services revenues	11,279	7,084	22,345	14,618
Gross profit	6,796	4,372	12,610	9,323
Home Health [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	4,572	2,641	9,109	5,521
Operating income	$ 2,224	$ 1,731	$ 3,501	$ 3,802

Segment Information (Segment Re

Segment Information (Segment Reconciliation to Totals reported in the accompanying Consolidated Financial Statements) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting Information [Line Items]
Operating income	$ 26,181	$ 21,539	$ 49,826	$ 40,147
Other general and administrative expenses	28,565	25,721	56,207	50,251
Depreciation and amortization	3,401	3,382	6,870	6,829
Interest income	(474)	(291)	(897)	(397)
Interest expense	2,114	2,331	4,872	4,792
Income before income taxes	24,541	19,499	45,851	35,752
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income	$ 58,147	$ 50,642	$ 112,903	$ 97,227

Significant Payors (Revenue by

Significant Payors (Revenue by Payor Type) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Net service revenues	$ 286,922	$ 259,980	$ 567,668	$ 511,579
Personal Care [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	212,817	198,314	420,820	388,346
Personal Care [Member] | Revenues [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 212,817	$ 198,314	$ 420,820	$ 388,346
Concentration risk, percentage	100%	100%	100%	100%
Personal Care [Member] | Revenues [Member] | Customer Concentration Risk [Member] | State, Local And Other Governmental Programs [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 113,002	$ 100,399	$ 220,756	$ 195,721
Concentration risk, percentage	53.10%	50.60%	52.50%	50.40%
Personal Care [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Managed Care Organizations [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 94,135	$ 91,276	$ 188,411	$ 179,176
Concentration risk, percentage	44.20%	46%	44.80%	46.10%
Personal Care [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Private Pay [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 3,689	$ 4,137	$ 7,595	$ 8,363
Concentration risk, percentage	1.70%	2.20%	1.80%	2.20%
Personal Care [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Commercial Insurance [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 1,467	$ 1,637	$ 2,953	$ 3,306
Concentration risk, percentage	0.70%	0.80%	0.70%	0.90%
Personal Care [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 524	$ 865	$ 1,105	$ 1,780
Concentration risk, percentage	0.30%	0.40%	0.20%	0.40%
Hospice [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 56,030	$ 50,210	$ 111,893	$ 99,292
Hospice [Member] | Revenues [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 56,030	$ 50,210	$ 111,893	$ 99,293
Concentration risk, percentage	100%	100%	100%	100%
Hospice [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Medicare [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 51,122	$ 45,566	$ 101,774	$ 90,122
Concentration risk, percentage	91.20%	90.70%	91%	90.80%
Hospice [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Managed Care Organizations [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 1,880	$ 1,567	$ 3,697	$ 3,214
Concentration risk, percentage	3.40%	3.10%	3.30%	3.20%
Hospice [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Commercial Insurance [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 2,844	$ 2,726	$ 5,978	$ 5,273
Concentration risk, percentage	5.10%	5.40%	5.30%	5.30%
Hospice [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 184	$ 351	$ 444	$ 684
Concentration risk, percentage	0.30%	0.80%	0.40%	0.70%
Home Health [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 18,075	$ 11,456	$ 34,955	$ 23,941
Home Health [Member] | Revenues [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 18,075	$ 11,456	$ 34,955	$ 23,941
Concentration risk, percentage	100%	100%	100%	100%
Home Health [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Medicare [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 12,517	$ 8,716	$ 24,180	$ 17,988
Concentration risk, percentage	69.30%	76.10%	69.20%	75.10%
Home Health [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Managed Care Organizations [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 4,676	$ 2,251	$ 9,076	$ 4,789
Concentration risk, percentage	25.90%	19.60%	26%	20%
Home Health [Member] | Revenues [Member] | Customer Concentration Risk [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net service revenues	$ 882	$ 489	$ 1,699	$ 1,164
Concentration risk, percentage	4.80%	4.30%	4.80%	4.90%

Significant Payors (Revenue b_2

Significant Payors (Revenue by Geographic Location) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Net service revenues	$ 286,922	$ 259,980	$ 567,668	$ 511,579
Revenues [Member] | Geographic Concentration Risk [Member] | Illinois [Member]
Concentration risk, percentage	38.60%	40%	38.50%	39.50%
Personal Care [Member]
Net service revenues	$ 212,817	$ 198,314	$ 420,820	$ 388,346
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member]
Net service revenues	$ 212,817	$ 198,314	$ 420,820	$ 388,346
Concentration risk, percentage	100%	100%	100%	100%
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Illinois [Member]
Net service revenues	$ 110,774	$ 103,864	$ 218,349	$ 202,279
Concentration risk, percentage	52.10%	52.40%	51.90%	52.10%
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | New Mexico [Member]
Net service revenues	$ 28,644	$ 27,907	$ 57,611	$ 56,381
Concentration risk, percentage	13.50%	14.10%	13.70%	14.50%
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | New York [Member]
Net service revenues	$ 23,299	$ 23,841	$ 46,833	$ 45,727
Concentration risk, percentage	10.90%	12%	11.10%	11.80%
Personal Care [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | All Other States [Member]
Net service revenues	$ 50,100	$ 42,702	$ 98,027	$ 83,959
Concentration risk, percentage	23.50%	21.50%	23.30%	21.60%
Hospice [Member]
Net service revenues	$ 56,030	$ 50,210	$ 111,893	$ 99,292
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member]
Net service revenues	$ 56,030	$ 50,210	$ 111,893	$ 99,293
Concentration risk, percentage	100%	100%	100%	100%
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Ohio [Member]
Net service revenues	$ 20,633	$ 19,332	$ 40,869	$ 37,783
Concentration risk, percentage	36.80%	38.50%	36.50%	38.10%
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Illinois [Member]
Net service revenues	$ 13,003	$ 11,606	$ 25,255	$ 23,087
Concentration risk, percentage	23.20%	23.10%	22.60%	23.30%
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | New Mexico [Member]
Net service revenues	$ 6,895	$ 6,540	$ 14,410	$ 13,026
Concentration risk, percentage	12.30%	13%	12.90%	13.10%
Hospice [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | All Other States [Member]
Net service revenues	$ 15,499	$ 12,732	$ 31,359	$ 25,397
Concentration risk, percentage	27.70%	25.40%	28%	25.50%
Home Health [Member]
Net service revenues	$ 18,075	$ 11,456	$ 34,955	$ 23,941
Home Health [Member] | Revenues [Member] | Geographic Concentration Risk [Member]
Net service revenues	$ 18,075	$ 11,456	$ 34,955	$ 23,941
Concentration risk, percentage	100%	100%	100%	100%
Home Health [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Illinois [Member]
Net service revenues	$ 3,042	$ 3,363	$ 5,984	$ 6,732
Concentration risk, percentage	16.80%	29.40%	17.10%	28.10%
Home Health [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | New Mexico [Member]
Net service revenues	$ 8,300	$ 8,093	$ 16,077	$ 17,209
Concentration risk, percentage	45.90%	70.60%	46%	71.90%
Home Health [Member] | Revenues [Member] | Geographic Concentration Risk [Member] | Tennessee
Net service revenues	$ 6,733		$ 12,894
Concentration risk, percentage	37.30%		36.90%

Significant Payors (Narrative)

Significant Payors (Narrative) (Details) - Illinois [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Revenues [Member] | Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	21.10%	21.50%	20.90%	21.50%
Revenues [Member] | Geographic Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.60%	40%	38.50%	39.50%
Accounts Receivable [Member] | Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			21.70%		20.70%